Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2019-02-19 Regulatory Filings
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Bio-Gate baut Veterinargeschaft weiter aus und erschliet neue Markte
Regulatory Filings Classification · 100% confidence The document is a press release dated February 19, 2019, issued by Bio-Gate AG, detailing business expansion, new license agreements, and product applications (veterinary foam, coatings). It uses keywords like "PRESSEINFORMATION" (Press Information), announces business developments ("baut Veterinärgeschäft weiter aus"), and includes standard disclaimers typical of corporate news releases distributed via services like DGAP/EQS Group. This content structure—announcing strategic business updates rather than releasing formal periodic financial statements (like 10-K or IR) or specific shareholder meeting materials—best fits the general category for corporate news announcements that are not covered by more specific codes. Since it is a general corporate announcement about business strategy and expansion, and not a formal regulatory filing like a 10-K, or a specific event like an AGM or Earnings Release, the most appropriate classification is Regulatory Filings (RNS) as a general corporate news item, although it strongly resembles an Earnings Release (ER) in format, it lacks specific period-end financial results. Given the focus on expansion and licensing, it is a general corporate update, making RNS the best fit among the provided options for non-standard, non-financial-period-specific news.
2019-02-19 German
Bio-Gate AG schliet Pre-Submission-Antrag bei der FDA bezuglich ihrer HyProtect(TM)-Beschichtungstechnologie ab
Regulatory Filings Classification · 99% confidence The document is a short announcement dated January 25, 2019, labeled as 'Ad-hoc' and 'Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014' (Insider Information according to MAR). It details that Bio-Gate AG has completed a Pre-Submission application with the FDA regarding its HyProtect(TM) coating technology. This type of specific, time-sensitive corporate disclosure, often mandated by EU regulations (MAR Article 17) and distributed via services like DGAP/EQS, typically falls under general regulatory announcements that don't fit the more specific financial report categories (like 10-K, ER, IR). Since it is not a full report, but a specific regulatory update, and it doesn't fit perfectly into DIRS, DIV, or CAP, the most appropriate general category for significant, non-financial-result-focused regulatory news is 'Regulatory Filings' (RNS). The length is short (3251 chars), but the content is substantive news, not just an announcement *of* another report, making RNS a better fit than RPA.
2019-01-25 German
Datum:07.01.2019
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Bio-Gate AG for the fiscal year 2017. It contains a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and detailed notes (Anhang) covering accounting principles, asset valuation, and equity details. As it provides comprehensive financial statements for the full fiscal year, it is classified as an Annual Report (10-K). FY 2017
2019-01-07 German
Bio-Gate AG passt Prognose fur 2018 an
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc-Mitteilung' (Ad-hoc announcement) dated November 30, 2018, published under Article 17 of the EU Market Abuse Regulation (MAR). The content explicitly states that the company is adjusting its forecast for 2018, specifically noting that the break-even point will not be reached and providing details on revenue stability and expected negative net results. This type of immediate, material financial disclosure, often referred to as a profit warning or guidance revision, is best classified as an Earnings Release (ER) as it communicates key financial performance expectations/changes for a period, even if it's not the final detailed report. It is not a full Annual Report (10-K) or an Interim Report (IR), but rather a preliminary announcement of results/outlook change. FY 2018
2018-11-30 German
Bio-Gate AG starkt im ersten Halbjahr 2018 Basis fur zukunftiges Wachstum
Earnings Release Classification · 100% confidence The document is titled 'PRESSEINFORMATION' and explicitly discusses the financial results for the 'ersten Halbjahr 2018' (first half of 2018), detailing revenue, EBITDA, net result, and cash flow figures. It also includes a forward-looking statement ('Ausblick 2018 bestätigt'). This content structure—a summary of period-specific financial performance that is not the full annual report (10-K) or a standalone audit report (AR)—is characteristic of an Interim/Quarterly Report (IR). The text also mentions that the 'Halbjahresbericht 2018' (Half-Year Report 2018) is available elsewhere, confirming this document is the press release summarizing those results, which aligns best with the Interim Report (IR) category, as it provides comprehensive period results, unlike a brief Earnings Release (ER). H1 2018
2018-09-13 German
Bio-Gate AG: Bio-Gate AG verstarkt Fuhrungsteam
Board/Management Information Classification · 100% confidence The document is a press release dated June 7, 2018, announcing that Bio-Gate AG is strengthening its management team by appointing Dr. Amir Al-Munajjed as the new Technical Director/CTO. This content directly relates to changes in senior management personnel. According to the definitions, announcements of changes in the company's board of directors or senior management fall under the 'Board/Management Information' category, which corresponds to the code MANG.
2018-06-07 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.